0000897069-24-000919.txt : 20240412
0000897069-24-000919.hdr.sgml : 20240412
20240412165251
ACCESSION NUMBER: 0000897069-24-000919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240412
DATE AS OF CHANGE: 20240412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bigora Sian
CENTRAL INDEX KEY: 0001799365
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39531
FILM NUMBER: 24842141
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
4
1
form4.xml
X0508
4
2024-01-01
0001533743
Processa Pharmaceuticals, Inc.
PCSA
0001799365
Bigora Sian
C/O PROCESSA PHARMACEUTICALS, INC.
7380 COCA COLA DRIVE, SUITE 106
HANOVER
MD
21076
true
Chief Development Officer
false
Common Stock
2024-01-01
4
M
0
1675
A
21826
D
Common Stock
2024-01-01
4
F
0
368
2.79
D
21458
D
Common Stock
6668
I
By CorLyst, LLC
Restricted Stock Units
0
2024-01-01
4
M
0
1675
0
D
Common Stock
1675
22139
D
Distribution of vested restricted shares.
Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
2024-04-12